128 related articles for article (PubMed ID: 31351131)
21. The influence of TNF-α on the expression profile of key enzymes of steroidogenesis in H295R cells.
Grabarek B; Cholewa K; Lodowska J
Postepy Dermatol Alergol; 2021 Jun; 38(3):404-411. PubMed ID: 34377120
[TBL] [Abstract][Full Text] [Related]
22. Developing the novel diagnostic model and potential drugs by integrating bioinformatics and machine learning for aldosterone-producing adenomas.
Yu D; Zhang J; Li X; Xiao S; Xing J; Li J
Front Mol Biosci; 2023; 10():1308754. PubMed ID: 38239411
[No Abstract] [Full Text] [Related]
23. Intratumoral heterogeneity of the tumor cells based on in situ cortisol excess in cortisol-producing adenomas; ∼An association among morphometry, genotype and cellular senescence∼.
Gao X; Yamazaki Y; Tezuka Y; Pieroni J; Ishii K; Atsumi N; Ono Y; Omata K; Morimoto R; Nakamura Y; Satoh F; Sasano H
J Steroid Biochem Mol Biol; 2020 Nov; 204():105764. PubMed ID: 33002589
[TBL] [Abstract][Full Text] [Related]
24. The Effect of Extracellular Calcium Metabolism on Aldosterone Biosynthesis in Physiological and Pathological Status.
Gao X; Yamazaki Y; Tezuka Y; Omata K; Ono Y; Morimoto R; Nakamura Y; Satoh F; Sasano H
Horm Metab Res; 2020 Jun; 52(6):448-453. PubMed ID: 32403152
[TBL] [Abstract][Full Text] [Related]
25. Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.
De Sousa K; Boulkroun S; Baron S; Nanba K; Wack M; Rainey WE; Rocha A; Giscos-Douriez I; Meatchi T; Amar L; Travers S; Fernandes-Rosa FL; Zennaro MC
Hypertension; 2020 Apr; 75(4):1034-1044. PubMed ID: 32114847
[TBL] [Abstract][Full Text] [Related]
26. p16 in highly malignant esophageal carcinomas: the correlation with clinicopathological factors and human papillomavirus infection.
Ishida H; Kasajima A; Fujishima F; Akaishi R; Ueki S; Yamazaki Y; Onodera Y; Gao X; Okamoto H; Taniyama Y; Kamei T; Sasano H
Virchows Arch; 2021 Feb; 478(2):219-229. PubMed ID: 32556556
[TBL] [Abstract][Full Text] [Related]
27. Histological Characterization of Aldosterone-producing Adrenocortical Adenomas with Different Somatic Mutations.
Ono Y; Yamazaki Y; Omata K; Else T; Tomlins SA; Rhayem Y; Williams TA; Reincke M; Carling T; Monticone S; Mulatero P; Beuschlein F; Ito S; Satoh F; Rainey WE; Sasano H
J Clin Endocrinol Metab; 2020 Mar; 105(3):e282-9. PubMed ID: 31789380
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis and treatment of primary aldosteronism.
Zennaro MC; Boulkroun S; Fernandes-Rosa FL
Nat Rev Endocrinol; 2020 Oct; 16(10):578-589. PubMed ID: 32724183
[TBL] [Abstract][Full Text] [Related]
29. Histopathological Analysis of Tumor Microenvironment and Angiogenesis in Pheochromocytoma.
Gao X; Yamazaki Y; Pecori A; Tezuka Y; Ono Y; Omata K; Morimoto R; Nakamura Y; Satoh F; Sasano H
Front Endocrinol (Lausanne); 2020; 11():587779. PubMed ID: 33244312
[TBL] [Abstract][Full Text] [Related]
30. Primary Aldosteronism and Bone Metabolism: A Systematic Review and Meta-Analysis.
Shi S; Lu C; Tian H; Ren Y; Chen T
Front Endocrinol (Lausanne); 2020; 11():574151. PubMed ID: 33101208
[TBL] [Abstract][Full Text] [Related]
31. Surgical treatment outcome of primary aldosteronism assessed using new modified diagnostic tests.
Alexandraki KI; Markou A; Papanastasiou L; Tyfoxylou E; Kapsali C; Gravvanis C; Katsiveli P; Kaltsas GA; Zografos GN; Chrousos GP; Piaditis G
Hormones (Athens); 2021 Jun; 20(2):359-368. PubMed ID: 33755936
[TBL] [Abstract][Full Text] [Related]
32. The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma.
Oki K; Gomez-Sanchez CE
Endocr J; 2020 Oct; 67(10):989-995. PubMed ID: 32968034
[TBL] [Abstract][Full Text] [Related]
33. Primary and Secondary Hyperparathyroidism in Patients with Primary Aldosteronism - Findings From the German Conn's Registry.
Asbach E; Bekeran M; König A; Lang K; Hanslik G; Treitl M; Ladurner R; Bidlingmaier M; Beuschlein F; Quinkler M; Reincke M
Exp Clin Endocrinol Diabetes; 2020 Apr; 128(4):246-254. PubMed ID: 31698477
[TBL] [Abstract][Full Text] [Related]
34. Acute effects of intravenous sodium chloride load on calcium metabolism and on parathyroid function in patients with primary aldosteronism compared with subjects with essential hypertension.
Rossi E; Perazzoli F; Negro A; Sani C; Davoli S; Dotti C; Casoli MC; Regolisti G
Am J Hypertens; 1998 Jan; 11(1 Pt 1):8-13. PubMed ID: 9504444
[TBL] [Abstract][Full Text] [Related]
35. Primary Aldosteronism with Parathyroid Hormone Elevation: A Single-center Retrospective Study.
Kometani M; Yoneda T; Aono D; Gondoh-Noda Y; Matsuoka T; Higashitani T; Yoshikura S; Sawada K; Takeda Y; Fujimoto A; Karashima S; Usukura M; Takeda Y
Intern Med; 2021; 60(7):993-998. PubMed ID: 33790140
[TBL] [Abstract][Full Text] [Related]
36. Correlation between plasma aldosterone concentration and bone mineral density in middle-aged and elderly hypertensive patients: potential impact on osteoporosis and future fracture risk.
Song S; Cai X; Hu J; Zhu Q; Shen D; Heizhati M; Yang W; Hong J; Li N
Front Endocrinol (Lausanne); 2024; 15():1373862. PubMed ID: 38808106
[TBL] [Abstract][Full Text] [Related]
37. Severe Hypercalcemia Caused by Calcium-Alkali Syndrome after 15 Years of Postoperative Hypoparathyroidism in a Patient with Undiagnosed Hyperaldosteronism.
Boufleuer ND; Rados DV; Zambonato T; Maraschin CK; Schaan BD
Case Rep Endocrinol; 2024; 2024():3067354. PubMed ID: 38404648
[TBL] [Abstract][Full Text] [Related]
38. Cross-Disciplinary Approach of Adrenal Tumors: Insights into Primary Aldosteronism-Related Mineral Metabolism Status and Osteoporotic Fracture Risk.
Trandafir AI; Gheorghe AM; Sima OC; Ciuche A; Petrova E; Nistor C; Carsote M
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139166
[TBL] [Abstract][Full Text] [Related]
39. Bone and mineral metabolism in patients with primary aldosteronism: A systematic review and meta-analysis.
Wang A; Wang Y; Liu H; Hu X; Li J; Xu H; Nie Z; Zhang L; Lyu Z
Front Endocrinol (Lausanne); 2022; 13():1027841. PubMed ID: 36387892
[TBL] [Abstract][Full Text] [Related]
40. Hypomethylation associated vitamin D receptor expression in ATP1A1 mutant aldosterone-producing adenoma.
Nanao Y; Oki K; Kobuke K; Itcho K; Baba R; Kodama T; Otagaki Y; Okada A; Yoshii Y; Nagano G; Ohno H; Arihiro K; Gomez-Sanchez CE; Hattori N; Yoneda M
Mol Cell Endocrinol; 2022 May; 548():111613. PubMed ID: 35257799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
